Research Article

Related GMR Articles

12/02/2013
Bone mesenchymal stem cells; OCT4; Overexpression; SOX2; Xiaomeishan porcine

Mesenchymal stem cells derived from bone marrow (BMSCs) are a population of self-renewing multipotent cells that are capable of differentiating into various cellular lineages, and are widely employed in tissue engineering and cell therapy. Recently, clinical research involving BMSCs has become increasingly popular. In order to conduct appropriate research, it is first necessary to amplify ... more

Y.X. Fan; C.H. Gu; Y.L. Zhang; B.S. Zhong; L.Z. Wang; Z.R. Zhou; Z.Y. Wang; R.X. Jia; F. Wang
07/08/2013
Endothelial nitric oxide synthase; Intervertebral disc degeneration; Polymorphism; Vascular endothelial growth factor

Disturbances in blood flow to intervertebral discs (IVD) play an important role in IVD degeneration. Vascular endothelial growth factor (VEGF) and endothelial nitric oxide synthase (eNOS) are extremely important angiogenic factors for vasodilation and neovascularization. We investigated the relationship between single nucleotide polymorphisms (SNPs) of the VEGF and eNOS ... more

I.B. Han; A.E. Ropper; Y.D. Teng; D.A. Shin; Y.J. Jeon; H.M. Park; D.E. Shin; Y.S. Park; K.N. Kim; N.K. Kim
06/13/2013
Asian; Cancer; Single nucleotide polymorphism; Vascular endothelial growth factor

Vascular endothelial growth factor (VEGF), the most important regulator of angiogenesis and vascular permeability, is involved in various steps of carcinogenesis. The +936C/T polymorphism of the VEGF gene has been reported to affect the VEGF protein level and to be related to the susceptibility of cancer. However, the results of published studies, as well as the subsequent meta-analyses, ... more

X.L. Liu; Q.F. Yang; B.H. Kong
04/02/2013
Bladder cancer; Recurrence; Survivin; Vascular endothelial growth factor

Survivin and vascular endothelial growth factor (VEGF) are newly discovered tumor markers closely correlated with bladder cancer. We analyzed the expression of survivin and VEGF in paraffin-embedded tumor tissues from 78 patients with bladder transitional cell carcinoma (BTCC) using an immunohistochemistry method. Normal bladder mucosae from 10 non-BTCC cases were also included as a ... more

Y.W. Sun; Q. Xuan; Q.A. Shu; S.S. Wu; H. Chen; J. Xiao; P. Xiang; Y.P. Zhu; F.L. Wang; S.T. Zhao
01/24/2014
Hypoxia-inducible factor-1α; Keratinocytes; Nerve growth factor; Psoriasis; Vascular endothelial growth factor

Decades of research have provided the data to confirm the hypothesis that there is bidirectional communication between the central nervous system and the immune system in psoriasis pathogenesis, but the contribution of the cutaneous neural system remains underexplored. In this study, we evaluated the molecular mechanisms by which nerve growth factor (NGF) regulates hypoxia-inducible ... more

J. Zhang; W.Y. Ma
10/27/2014
Metabolic syndrome; Plasminogen activator inhibitor-1; Vascular endothelial growth factor; Vascular endothelium dysfunction; von Willebrand factor

We aimed at investigating the association between metabolic syndrome (MS) and vascular endothelial cell dysfunction (ECD) in children and adolescents. Sixty children (30 obese children and 30 children with MS) were included in this retrospective analysis. Thirty healthy subjects were randomly selected as the control group. A series of indices/biomarkers known to be related to MS/ECD were ... more

Y. Wei; G.L. Liu; J.Y. Yang; R.X. Zheng; L.H. Jiang; Y.P. Li; F.F. Gao
10/31/2014
Clinical outcome; Hepatocellular carcinoma; Polymorphism; Vascular endothelial growth factor

We conducted a cohort study to investigate the prognostic significance of vascular endothelial growth factor (VEGF) polymorphisms in hepatocellular carcinoma (HCC) patients after transcatheter arterial chemoembolization (TACE). In total, 156 patients with histologically confirmed HCC within 2 months were collected from January 2007 to January 2008. The genotypes of VEGF-2578C/A ... more

J. Song; L.Z. Wang; X. Li; T.P. Jiang; T.Z. An; M. Xu; X.P. Wu; S. Zhou
08/25/2014
Hypopharyngeal neoplasms; Immunohistochemistry; Integrin β1; Microvascular density; Squamous cell carcinoma; Vascular endothelial growth factor

This study aimed to determine the expression of integrin β1 and vascular endothelial growth factor (VEGF) and microvascular density (MVD) by CD105 staining in hypopharyngeal squamous cell carcinoma to determine their association with clinicopathologic characteristics, and to determine their role and the effects of their interactions in the development and progression of hypopharyngeal ... more

Y.M. Hong; W.G. Gan; Z.H. Xu
07/25/2014
Colorectal cancer; Epidermal growth factor; Vascular endothelial growth factor

Growth factors are polypeptides that are critical for the initiation, progression, and metastasis of cancer. Most tumor cells are capable of synthesizing particular growth factors leading to constitutive pathway activation in these cells through autocrine signaling. Epidermal growth factor (EGF) is a potent mitogenic peptide that exerts direct effects on the proliferation and ... more

T.P. Lau; A.C. Roslani; L.H. Lian; P.C. Lee; I. Hilmi; K.L. Goh; K.H. Chua
07/07/2014
Cervical cancer; Radiosensitivity; RNA interference; SiHa cells; Vascular endothelial growth factor

This study aimed to investigate the inhibition of vascular endothelial growth factor (VEGF) by small hairpin RNA (shRNA) interference combined with radiotherapy on the growth of cervical cancer SiHa cell xenografts in nude mice. The effective pVEGF-shRNA plasmid was screened by reverse transcription-polymerase chain reaction (RT-PCR), and the cell apoptosis rate was estimated by flow ... more

L. Qi; L.N. Xing; X. Wei; S.G. Song

Pages